Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
1.
Arch Dis Child ; 89(5): 399-400, 2004 May.
Article in English | MEDLINE | ID: mdl-15102622
3.
Cochrane Database Syst Rev ; (1): CD003966, 2003.
Article in English | MEDLINE | ID: mdl-12535494

ABSTRACT

BACKGROUND: The optimal duration of oral antibiotic therapy for urinary tract infection (UTI) in children has not been determined. A number of studies have compared single dose therapy to standard therapy for UTI, with mixed results. A course of antibiotics longer than a single dose but shorter than the usual 7-10 days might decrease the relapse rate and still provide some of the benefits of a shortened course of antibiotics. OBJECTIVES: The objective of this review was to assess the benefits and harms of short-course (2-4 days) compared to standard duration (7-14 days) oral antibiotic treatment for acute UTI in children. SEARCH STRATEGY: We searched the Cochrane Controlled Trials Register (Cochrane Library Issue 3, 2002) MEDLINE (1966 - September 2002) and EMBASE (1988 -September 2002) without language restriction. SELECTION CRITERIA: Randomised and quasi-randomised controlled trials comparing short-term (2-4 days) with standard (7-14 days) oral antibiotic therapy were selected if they studied children aged three months to 18 years with culture proven UTI. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed trial quality and extracted data. Statistical analyses were performed using the random effects model and the results expressed as relative risk (RR) with 95% confidence intervals (95% CI). MAIN RESULTS: Ten trials were identified in which 652 children with lower tract UTI were evaluated. There was no significant difference in the frequency of positive urine cultures between the short (2-4 days) and standard duration oral antibiotic therapy (7-14 days) for UTI in children at 0-10 days after treatment (eight studies: RR 1.06; 95% CI 0.64 to 1.76) and at one to 15 months after treatment (10 studies: RR 0.95; 95% CI 0.70 to 1.29). There was no significant difference between short and standard duration therapy in the development of resistant organisms in UTI at the end of treatment (one study: RR 0.57, 95% CI 0.32 to 1.01) or in recurrent UTI (three studies: RR 0.39, 95% CI 0.12 to 1.29). REVIEWER'S CONCLUSIONS: A 2-4 day course of oral antibiotics appears to be as effective as 7-14 days in eradicating lower tract UTI in children.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Anti-Infective Agents, Urinary/administration & dosage , Urinary Tract Infections/drug therapy , Acute Disease , Administration, Oral , Adolescent , Child , Female , Humans , Infant , Infant, Newborn , Male , Randomized Controlled Trials as Topic , Treatment Outcome
4.
J Paediatr Child Health ; 38(4): 347-51, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12173994

ABSTRACT

OBJECTIVE: To determine whether management provided to paediatric inpatients in general units was supported by high-level evidence. METHODS: A retrospective review was carried out of all patients (n = 142) admitted during one calendar month to two general paediatric units in the USA and Australia. For each patient, the primary diagnosis and primary treatment were determined. A literature review was performed to determine whether the therapy used was evidence-based. The main outcome measure was the level of evidence supporting the primary intervention for the primary diagnosis of each patient. RESULTS: Level I evidence (at least one randomized trial) supported the primary intervention used in 31% of paediatric admissions and level II evidence (convincing non-experimental evidence) supported the primary intervention in 44% of admissions. Primary interventions were not supported by evidence (level III) in only two patients. The remaining 24% of patients were admitted for observation or evaluation only, and received no primary medical or surgical intervention. Most patients whose interventions were supported by randomized trials were admitted with either asthma or appendicitis. CONCLUSIONS: Most primary interventions (75%) in paediatric inpatients were supported by high-level published evidence (level I or II). A large number of patients were admitted for evaluation or observation only, and received no therapeutic intervention. Evidence to support this action is not available.


Subject(s)
Evidence-Based Medicine , Hospital Departments/standards , Pediatrics/standards , Quality of Health Care , Adolescent , Child , Child, Preschool , Humans , Infant , Infant, Newborn , New South Wales , Retrospective Studies , Texas
5.
Cochrane Database Syst Rev ; (3): CD001695, 2002.
Article in English | MEDLINE | ID: mdl-12137629

ABSTRACT

BACKGROUND: Congenital diaphragmatic hernia, although rare (1 per 2-4,000 births), is associated with high mortality and cost. Opinion regarding the timing of surgical repair has gradually shifted from emergent repair to a policy of stabilization using a variety of ventilatory strategies prior to operation. Whether delayed surgery is beneficial remains controversial. OBJECTIVES: To summarize the available data regarding whether surgical repair in the first 24 hours after birth rather than later than 24 hours of age improves survival to hospital discharge in infants with congenital diaphragmatic hernia who are symptomatic at or immediately after birth. SEARCH STRATEGY: Search of MEDLINE (1966-2002), EMBASE (1978-2002) and the Cochrane databases using the terms "congenital diaphragmatic hernia" and "surg*"; citations search, and contact with experts in the field to locate other published and unpublished studies. SELECTION CRITERIA: Studies were eligible for inclusion if they were randomized or quasi-randomized trials that addressed infants with CDH who were symptomatic at or shortly after birth, comparing early (<24 hours) vs late (>24 hours) surgical intervention, and evaluated mortality as the primary outcome. DATA COLLECTION AND ANALYSIS: Data were collected regarding study methods and outcomes including mortality, need for ECMO and duration of ventilation, both from the study reports and from personal communication with investigators. Analysis was performed in accordance with the standards of the Cochrane Neonatal Review Group. MAIN RESULTS: Two trials met the pre-specified inclusion criteria for this review. Both were small trials (total n<90) and neither showed any significant difference between groups in mortality. Meta-analysis was not performed because of significant clinical heterogeneity between the trials. REVIEWER'S CONCLUSIONS: There is no clear evidence which favors delayed (when stabilized) as compared with immediate (within 24 hours of birth) timing of surgical repair of congenital diaphragmatic hernia, but a substantial advantage to either one cannot be ruled out. A large, multicenter randomized trial would be needed to answer this question.


Subject(s)
Hernia, Diaphragmatic/surgery , Hernias, Diaphragmatic, Congenital , Age Factors , Hernia, Diaphragmatic/mortality , Humans , Infant, Newborn , Length of Stay , Prognosis , Randomized Controlled Trials as Topic , Time Factors
6.
Arch Dis Child ; 87(2): 118-23, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12138060

ABSTRACT

AIMS: To compare the effectiveness of short course (2-4 days) with standard duration oral antibiotic treatment (7-14 days) for urinary tract infection (UTI). METHODS: Meta-analysis of randomised controlled trials using a random effects model. Ten trials were eligible, involving 652 children with lower tract UTI recruited from outpatient or emergency departments. Main outcome measures were UTI at the end of treatment, UTI during follow up (recurrent UTI), and urinary pathogens resistant to the treating antibiotic. RESULTS: There was no significant difference in the frequency of positive urine cultures between the short (2-4 days) and standard duration therapy (7-14 days) for UTI in children at 0-7 days after treatment (eight studies: RR 1.06; 95% CI 0.64 to 1.76) and at 10 days to 15 months after treatment (10 studies: RR 1.01; 95% CI 0.77 to 1.33). There was no significant difference between short and standard duration therapy in the development of resistant organisms in UTI at the end of treatment (one study: RR 0.57, 95% CI 0.32 to 1.01) or in recurrent UTI (three studies: RR 0.39, 95% CI 0.12 to 1.29). CONCLUSION: A 2-4 day course of oral antibiotics is as effective as 7-14 days in eradicating lower tract UTI in children.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Urinary Tract Infections/drug therapy , Adolescent , Child , Child, Preschool , Drug Administration Schedule , Humans , Infant , Randomized Controlled Trials as Topic , Treatment Outcome
13.
West J Med ; 174(3): 158-9, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238333
14.
Ambul Pediatr ; 1(1): 53-8, 2001.
Article in English | MEDLINE | ID: mdl-11888372

ABSTRACT

Evidence syntheses, also known as systematic reviews, differ from traditional reviews in that they are scientific evaluations of existing studies. Systematic reviews have explicit and reproducible methods and, as with any other scientific endeavor, the result of an evidence synthesis or systematic review can be critically appraised. Many sources for high-quality evidence syntheses now exist, with considerable support from government agencies to develop both the methods and the products of such reviews. Evidence syntheses can increase the efficiency and effectiveness of medical practice but face many hurdles, particularly in child health. These center around 4 areas: lack of high-quality primary studies, the difficulty of finding studies that do exist, the variability and usefulness of the outcome measures in child health, and problems with production and dissemination. Increasing attention to the need for high-quality child health research will help to ameliorate some of these issues, whereas solutions to others are under development or remain elusive.


Subject(s)
Child Health Services/standards , Child Welfare , Health Services Research , Meta-Analysis as Topic , Child , Child, Preschool , Evidence-Based Medicine/standards , Female , Guidelines as Topic , Humans , Infant , Male , Sensitivity and Specificity
15.
J Pediatr Health Care ; 14(6): 264-9, 2000.
Article in English | MEDLINE | ID: mdl-11112918

ABSTRACT

Group B streptococcus (GBS) is the leading bacterial infection associated with morbidity and mortality of newborns in the United States. Most neonatal infections can be prevented through the use of intrapartum antimicrobial prophylaxis in women who are at increased risk for transmitting infection to their newborns. However, prevention strategies have not been implemented widely or consistently, and the incidence of neonatal GBS disease has not declined. An understanding of GBS epidemiology, clinical presentation, and prevention strategies enhances the PNP's decision-making skills in the nursery and strengthens the PNP's ability to evaluate and compare new approaches to GBS prevention.


Subject(s)
Infant, Newborn, Diseases/nursing , Pregnancy Complications, Infectious/nursing , Streptococcal Infections/nursing , Streptococcus agalactiae , Antibiotic Prophylaxis , Female , Humans , Infant, Newborn , Infant, Newborn, Diseases/epidemiology , Infant, Newborn, Diseases/prevention & control , Infectious Disease Transmission, Vertical/prevention & control , Nurse Practitioners , Nursing Assessment , Pregnancy , Pregnancy Complications, Infectious/epidemiology , Pregnancy Complications, Infectious/prevention & control , Streptococcal Infections/epidemiology , Streptococcal Infections/prevention & control , United States/epidemiology
16.
JAMA ; 284(7): 869-75, 2000 Aug 16.
Article in English | MEDLINE | ID: mdl-10938177

ABSTRACT

Clinicians rely on knowledge about the clinical manifestations of disease to make clinical diagnoses. Before using research on the frequency of clinical features found in patients with a disease, clinicians should appraise the evidence for its validity, results, and applicability. For validity, 4 issues are important-how the diagnoses were verified, how the study sample relates to all patients with the disease, how the clinical findings were sought, and how the clinical findings were characterized. Ideally, investigators will verify the presence of disease in study patients using credible criteria that are independent of the clinical manifestations under study. Also, ideally the study patients will represent the full spectrum of the disease, undergo a thorough and consistent search for clinical findings, and these findings will be well characterized in nature and timing. The main results of these studies are expressed as the number and percentages of patients with each manifestation. Confidence intervals can describe the precision of these frequencies. Most clinical findings occur with only intermediate frequency, and since these frequencies are equivalent to diagnostic sensitivities, this means that the absence of a single finding is rarely powerful enough to exclude the disease. Before acting on the evidence, clinicians should consider whether it applies to their own patients and whether it has been superseded by new developments. Detailed knowledge of the clinical manifestations of disease should increase clinicians' ability to raise diagnostic hypotheses, select differential diagnoses, and verify final diagnoses. JAMA. 2000;284:869-875


Subject(s)
Diagnosis , Evidence-Based Medicine , Publications , Reproducibility of Results
17.
Cochrane Database Syst Rev ; (3): CD001695, 2000.
Article in English | MEDLINE | ID: mdl-10908506

ABSTRACT

BACKGROUND: Congenital diaphragmatic hernia, although rare (1 per 2-4,000 births), is associated with high mortality and cost. Opinion regarding the timing of surgical repair has gradually shifted from emergent repair to a policy of stabilization using a variety of ventilatory strategies prior to operation. Whether delayed surgery is beneficial remains controversial. OBJECTIVES: To summarize the available data regarding whether surgical repair in the first 24 hours after birth rather than later than 24 hours of age improves survival to hospital discharge in infants with congenital diaphragmatic hernia who are symptomatic at or immediately after birth. SEARCH STRATEGY: Search of Medline (1966-1999), Embase (1978-1999) and the Cochrane databases using the terms "congenital diaphragmatic hernia" and "surg*"; citations search, and contact with experts in the field to locate other published and unpublished studies. SELECTION CRITERIA: Studies were eligible for inclusion if they were randomized or quasi-randomized trials that addressed infants with CDH who were symptomatic at or shortly after birth, comparing early (<24 hours) vs late (>24 hours) surgical intervention, and evaluated mortality as the primary outcome. DATA COLLECTION AND ANALYSIS: Data were collected regarding study methods and outcomes including mortality, need for ECMO and duration of ventilation, both from the study reports and from personal communication with investigators. Analysis was performed in accordance with the standards of the Cochrane Neonatal Review Group. MAIN RESULTS: Two trials met the pre-specified inclusion criteria for this review. Both were small trials (total n<90) and neither showed any significant difference between groups in mortality. Meta-analysis was not performed because of significant clinical heterogeneity between the trials. REVIEWER'S CONCLUSIONS: There is no clear support for either immediate (within 24 hours of birth) or delayed (until stabilized) repair of congenital diaphragmatic hernia, but a substantial advantage to either one cannot be ruled out. A large, multicenter randomized trial would be needed to answer this question.


Subject(s)
Hernia, Diaphragmatic/surgery , Hernias, Diaphragmatic, Congenital , Age Factors , Hernia, Diaphragmatic/mortality , Humans , Infant, Newborn , Length of Stay , Prognosis , Randomized Controlled Trials as Topic , Time Factors
18.
Arch Pediatr Adolesc Med ; 154(4): 391-4, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10768679

ABSTRACT

CONTEXT: Recommendations for management of jaundice in newborns presume thatjaundice is a reliable clinical finding and that the pattern and intensity of jaundice reflects the degree of elevation of the serum bilirubin level. OBJECTIVES: To determine whether experienced observers agree in describing the extent of jaundice and to evaluate the reliability of visual assessment as an indication for the measurement of serum bilirubin levels. DESIGN: Comparison of independent judgments of the extent of jaundice between examiners and with actual serum bilirubin measurements. SETTING: Well-newborn nursery in an urban public hospital. PARTICIPANTS: A convenience sample of 122 healthy term newborns whose bilirubin concentration was measured in the course of standard newborn care. Observers were experienced pediatric nurse practitioners, pediatric house staff, and pediatric attending physicians. RESULTS: Agreement was moderately good for whether an infant's skin was darkly pigmented (K = 0.56). However, agreement between observers regarding the presence of jaundice at each specific body site was poor (0%-23% agreement beyond chance); correlation between estimated bilirubin concentrations was similarly poor (Pearson correlation coefficient, 0.37). Correlation between estimated and actual bilirubin values was slightly better (Pearson correlation coefficient, 0.43-0.54). CONCLUSIONS: Clinical examination with visual assessment for jaundice in newborns is neither reliable nor accurate. The decision to perform serum bilirubin testing should be based on additional factors.


Subject(s)
Clinical Competence , Jaundice, Neonatal/diagnosis , Bilirubin/blood , Female , Humans , Infant, Newborn , Male , Reproducibility of Results
19.
Arch Pediatr Adolesc Med ; 154(4): 411-3, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10768683

ABSTRACT

OBJECTIVE: To assess knowledge of the Denver II, the revised developmental screening tool recommended by the American Academy of Pediatrics, in residents and faculty, and to evaluate a teaching intervention for incoming postgraduate year 1 (PGY-1) trainees. DESIGN: A cross-sectional test of knowledge for all subjects and pretesting and posttesting of the incoming PGY- 1 trainees. SETTING: University of Texas-Houston Medical School Department of Pediatrics. PARTICIPANTS: Faculty (n = 9) and residents (n = 78), including an intervention group (n = 45), of incoming PGY-1 trainees over 2 years. INTERVENTIONS: Postgraduate year 1 trainees in both 1994 through 1995 and 1995 through 1996 viewed the Denver II training videotape on entry into a continuity clinic. Trainees were encouraged to perform Denver II evaluations on at least 1 appropriate patient at each pediatric clinic session and had access to Denver II support materials. MAIN OUTCOME MEASURES: Scores on the Denver II Proficiency Written Test, self-reported measures of comfort, and number of Denver II evaluations performed. RESULTS: The mean (SD) test scores for incoming, preintervention PGY-1 trainees (n = 45) (41.3 [9.6]) did not differ from scores for outgoing PGY-1 trainees (n = 13) (38.5 [10.4]) who had not received the intervention. Postintervention PGY-1 test results were significantly improved (59.4 [10.6]) (P<.001). Test scores for upper-level residents who had participated in the developmental pediatrics rotation (n = 14) were better (55.3 [9.31), but all scored below passing. Residents who had not yet participated in the developmental pediatrics rotation (n = 19) and members of the general pediatric faculty (n = 9) had scores similar to those of PGY-1 trainees (40.9 [13.4] and 39.0 [15.1], respectively). CONCLUSIONS: Residents had a greater knowledge of the Denver II after completing a developmental pediatrics rotation. Our intervention produced significant improvement in PGY-1 trainees' knowledge, raising it to levels similar to those of upper-level residents exposed to developmental pediatrics. Faculty were not expert in using the Denver II.


Subject(s)
Child Development , Health Status Indicators , Internship and Residency , Pediatrics/education , Child , Cross-Sectional Studies , Humans
20.
J Pediatr ; 136(3): 282-4, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10700681
SELECTION OF CITATIONS
SEARCH DETAIL
...